Rivastigmine

This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on February 8, 2020.

Return to the list of Patented Medicine Litigation page.





Rivastigmine

EXELON PATCH 10, EXELON PATCH 15, EXELON PATCH 5 – Novartis Pharmaceuticals Canada Inc. (NOC Search)

Patents:

  • 2315784: COBALT, MYLAN

COBALT

MYLAN


Return to the Patented Medicine Litigation page.

Canadian Intellectual Property